Navigation Links
Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
Date:6/9/2008

bipolar disorder are able to make informed decisions regarding their treatment in an acute agitated state and would prefer a treatment option that is rapid-acting and noninvasive.

Alexza believes there is a significant unmet medical need for an alternative treatment option for acute agitation that will provide a faster onset of effect, that is non-invasive and safe for medical personnel to administer, and will facilitate trust between the patient and the treating clinician.

About AZ-004 (Staccato loxapine)

AZ-004 is the combination of Alexza's proprietary Staccato system with loxapine, a drug belonging to the class of compounds known generally as atypical antipsychotics. The Staccato system technology used in AZ-004 is a hand-held, chemically-heated, single dose inhaler designed to generate and deliver excipient-free loxapine aerosol for deep lung delivery that results in IV-like pharmacokinetics. Alexza has now completed four clinical trials with AZ-004, this 344 patient Phase 3 study, a 50 subject Phase 1 study, a 129 patient Phase 2 study, and a 32 patient multiple-dose tolerability and PK study in schizophrenic patients.

The Company believes that the unique delivery of loxapine via the Staccato system will provide rapid onset of drug effect, as measured by a reduction in the signs and symptoms of acute agitation. In March 2007, Alexza announced positive initial results from a multi-center, randomized, double-blind, placebo-controlled Phase 2 clinical trial in 129 patients in an in-patient clinical setting. The 10 mg dose of AZ-004 met the primary endpoint of the clinical trial, which was a statistically significant reduction in the measure of agitation from baseline to the 2-hour post-dose time point, as compared to placebo. The 10 mg dose of AZ-004 also exhibited a rapid onset of effect, with a statistically significant improvement in the PEC scores at 20 minutes post-dose, as compared to placebo, and sustained effectiveness through
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... MC Medical, a subsidiary of Mitsubishi Corporation (MCM), and Minimally ... medical device company, have formally agreed to an exclusive ... in Japan . It is anticipated that ... in the latter half of 2015. ... in endoscopic surgery market in Japan . ...
(Date:8/22/2014)... ITHACA, N.Y. , Aug. 22, 2014 /PRNewswire/ ... computed tomography (CT) imaging facility, is using the ... 4D and even 5D imaging to researchers and ... just launched, asks "What would YOU do if ... the possibility to researchers and explorers everywhere, from ...
(Date:8/22/2014)... FREMONT, Calif. , Aug. 22, 2014  WaferGen ... an underwritten public offering of units of common stock ... for gross proceeds of $20 million, prior to deducting ... the Company.  The shares and warrants are immediately separable ... stock are expected to begin trading on The NASDAQ ...
Breaking Medicine Technology:MC Medical agrees to be the exclusive distributor of FloShield products in Japan 2Cornell's X-ray Imaging Lab Director Uses Kickstarter Campaign to "Democratize" Advanced 3D Imaging 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4
... , BOSTON, Nov. 20 The United States ... an earlier District Court ruling yesterday, approving a settlement ... against AstraZeneca Pharmaceuticals ( AZN). , (Logo: http://www.newscom.com/cgi-bin/prnh/20080317/AQM144LOGO ... consumers who purchased the pharmaceutical giant,s prostate cancer drug ...
... , LOUISVILLE, Ky., Nov. 20 ... a new initiative in the war on methamphetamine. The ... program that enforces purchase limitations on over-the-counter (OTC) medicines containing ... technology for NPLEx is based on a system that was ...
Cached Medicine Technology:U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 2National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 3
(Date:8/22/2014)... 2014 A new, online conference is coming ... summit is no-cost and open to everyone. Over 20 ... tips and advice on how to stop emotional eating, start ... Mindful eating is not a diet. The concept is ... of an "eat this, don't eat that" approach. , You ...
(Date:8/22/2014)... 22, 2014 For patients who need surgery for ... procedure is the least often used, reports a study ... , official journal of the Congress of Neurological ... Williams & Wilkins , a part of Wolters ... good pain relief at much lower cost than other ...
(Date:8/22/2014)... New York, NY (PRWEB) August 22, 2014 ... Theresa Caputo tickets in Kalamazoo, New Orleans, Albuquerque ... family after death, the “Long Island Medium,” Theresa Caputo, allows ... on Long Island. She is part of a close knit ... child. After speaking with a spiritual healer, realized she had ...
(Date:8/22/2014)... FL (PRWEB) August 22, 2014 ... continues expansion of products in providing new recipe cards, ... casual wear. , Hailing from Clearwater, Florida, Pirate ... appreciate having 1 card with two to three recipes ... the recipes on the website. The ...
(Date:8/22/2014)... According to the new research report "Isocyanate Market ... Forecast to 2019" defines and segments the isocyanate ... market value. The isocyanate material market value will ... significant CAGR from 2014 to 2019. , Browse ... through 286 pages and in-depth TOC on "Isocyanate ...
Breaking Medicine News(10 mins):Health News:20 Top Experts Discuss How to Unravel the Food-Mood Connection 2Health News:More common procedures for painful facial tics carry high costs, reports study in Neurosurgery 2Health News:Theresa Caputo Tickets in Kalamazoo at Wings Stadium, Saenger Theatre in New Orleans, Kiva Auditorium in Albuquerque and Rapid City at Don Barnett Arena Now Available 2Health News:Pirate Jonny's Caribbean BBQ Rubs, Seasonings & Sauces Get New Look by Hoisting New Recipe Card Creations and New Clothing Apparel for its Logos 2Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 2Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 3Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 4
... and Washington University School of Medicine in St. Louis have ... 16 to// use of all-terrain vehicles (ATVs). This call was ... ,Children have no experience or training in driving motorized vehicles, ... see what's coming up ahead of them very well,' says ...
... with Florida-based Roskamp Institute to conduct a study on ... in Alzheimer's disease. // ,The Dublin Ageing ... Psychiatry from St James’ Hospital, Beaumont Hospital, James Connolly ... Adelaide and Meath Hospital and St Patrick’s Hospital will ...
... herbs, has now uncorked a new product: herbal wine. // ... a resident of tourist town Pokhara in western Nepal, whose ... ,For many families, alcohol is an integral part of life, ... liquors thrive in Nepal's markets along with foreign beers, whiskeys ...
... tailoring the intensity of radiation to individual patients and ... for those// suffering medulloblastoma. ,A team ... has announced that improved treatment measures for childhood brain ... of children with this disease. , ,The ...
... strong bones, strong and healthy teeth, and healthy muscles and ... vital to take plenty of calcium, especially in the adolescent ... osteoporosis. ,The growth of bone mass takes place ... by calcium in milk, cheese, yogurt, other dairy products, leafy ...
... drugs are released within a cancer cells.// ,A ... first time ever details of how drugs are released within ... the ability to deliver drugs to a specific target without ... indiscriminate delivery of drugs into every cell of the body ...
Cached Medicine News:Health News:Call To Ban Use Of ATVs By Children 2Health News:Nepal Uncorks 'Herbal Wine' 2Health News:Survival rates improve with better treatment options for medulloblastoma 2Health News:Survival rates improve with better treatment options for medulloblastoma 3Health News:Study Findings Could Help In Developing A Better Drug Delivery System 2Health News:Study Findings Could Help In Developing A Better Drug Delivery System 3Health News:Study Findings Could Help In Developing A Better Drug Delivery System 4
Digital Ultrasonic Diagnostic Imaging System...
Quantitative Plasma-based Factor XIII Incorporation Assay Kit...
Pefakit PiCT LMWH Controls...
Calcium Chloride 0.020M - 4 ml...
Medicine Products: